Nationwide ABTA Survey Drove Development of New Educational Offering for Physicians, Nurses and Social Workers
The American Brain Tumor Association (ABTA), in joint sponsorship with Cleveland Clinic, will present the 15th Annual Brain Tumor Update and 4th Annual International Symposium on Long-term Control of Metastases to the Brain and Spine on Saturday, Nov. 9 and Sunday, Nov. 10 at the Bellagio Hotel in Las Vegas.
The first day of the conference will feature a new “Partners in Care” track developed by the ABTA specifically for nurses, social workers and physicians seeking to advance their knowledge of issues that directly impact brain tumor patients and their families. The track will address the care of patients with either metastatic or primary brain tumors.
Recently, the ABTA conducted an extensive survey of health care professionals from across the United States, the results of which informed the development of the “Partners in Care” conference track.
“Professional development is an important part of helping to move the brain tumor field forward, and health care professionals turn to the ABTA as a trusted resource,” says Mary Lovely, PhD, ABTA senior advisor, Mission Division, and course co-director. “Our recent needs assessment showed that the vast majority of health care professionals seek information about brain tumors, not only to assist patients, but also to increase their personal knowledge. And by far, their most preferred method of learning is the professional conference setting. In partnering with Cleveland Clinic, the ABTA can provide an important, sought-after educational opportunity to health care professionals who are interacting with patients and families every day.”
The “Partners in Care” session will identify specific, practical strategies for living with a brain tumor including symptom management, caregiver needs, palliative care and the financial aspects of brain tumor care. Nationally recognized experts will provide overviews of cerebral functions affected by brain tumors, common tumor types and treatments, assessing cognition changes, the management of fatigue and financial resources.
The second day of the conference will offer all attendees an opportunity to learn about updates in management of unusual tumors, advancements in the treatment of gliomas, new surgical techniques and more.
Individuals can choose to attend one or both days. For the full conference program and registration information, visit http://www.ccfcme.org/BrainMets13.
This activity has been approved for AMA PRA Category 1 Credits™. Continuing Education Units are available for nurses. This activity is pending approval from the National Association of Social Workers.
ABOUT THE AMERICAN BRAIN TUMOR ASSOCIATION
Founded in 1973, the American Brain Tumor Association was the first and is now the only national organization committed to funding brain tumor research and providing support and education programs for all tumor types and all age groups. For more information, visit http://www.abta.org.